Class 4 Drug Caution In Use - NAPROSYN TABLETS (ALL STRENGTHS), NAPROSYN EC 250MG GASTRO-RESISTANT TABLETS

Atnahs Pharma UK Limited have informed us that the Patient Information Leaflets (PILs) that have been provided with the below batches are missing information.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-atnahs-pharma-uk-limited-naprosyn-tablets-all-strengths-naprosyn-ec-250mg-gastro-resistant-tablets-el-22-a-slash-05?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=8020daee-edf4-40b6-942b-a17672984fb1&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For medical information queries or stock control queries, please contact: info@pharmanovia.com

If you have any questions, then please contact your local Service Centre Customer Services team.